Bortezomib in combination with dexamethasone for relapsed multiple myeloma
- 31 May 2005
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 29 (5) , 587-590
- https://doi.org/10.1016/j.leukres.2004.11.004
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myelomaOncogene, 2003
- Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletionZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaNew England Journal of Medicine, 2003
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998